As if low prices weren't enough for the oil market, it must not hold their breath in the face of a potential new law.» Read More
U.S. government debt prices were lower on Friday morning after the monthly jobs number came in lower than expected.
What's better to do on a Sunday afternoon than tackle global inequality?
A winter storm snarled the morning commute for millions of Americans from the Mid-Atlantic to New England Friday.
Despite his politically-incorrect stance on minorities and women, Trump's positions hold appeal for working class Democrats worried about the economy.
The auctions in London fell short of expectations. CNBC's Robert Frank looks at a turning art market.
After the Bank of Japan implemented negative rates, will the U.S. be next? CNBC contributor Ron Insana, provides perspective.
Where to invest in the oil patch, with Rusty Braziel, RBN Energy President and Principal energy markets consultant. Braziel says if you want to buy an oil stock, "look at companies investing in the lowest cost production region relative to the size of the well it's produced."
If you're really nervous about the market, I would lighten up now rather than later, explains Jonathan Clements, author of "Jonathan Clements Money Guide 2016," in providing strategies for savers.
"I intend to follow the advice of my counsel, and not yours," Martin Shkreli tells Rep. Trey Gowdy, smirking.
Goldman Sachs' head of commodities research Jeff Currie, said oil would fall into the $20 range and he was right. "We will get the production declines we need to actually begin to re balance this market by late third quarter, early fourth quarter of this year," he says.
Merrimack Pharmaceuticals develops products to treat cancer. President and CEO Bob Mulroy, shares his view of drug price hikes and whether the FDA is in the way of companies.
Barbara Mistick, author of "Stretch," a book about taking responsibility of your career, discusses the changing job world.
Rep. Jason Chaffetz (R-Utah), Chairman of the House Oversight & Government Committee, comments on former Turing Pharmaceuticals CEO Martin Shkreli's tweet calling the Congressional committee "imbeciles."
Warren Buffett has acquired another 1.69 million shares of Phillips 66, reports CNBC's Seema Mody.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Jefferies saying Therapeutics MD will double.
Rep. Jason Chaffetz (R-Utah), Chairman of the House Oversight & Government Committee, reflects on former Turing Pharmaceuticals CEO Martin Shkreli's behavior on Capitol Hill, and the debate on drug prices and the role of government.
CNBC's Michelle Caruso-Cabrera explains the fear over Deutsche Bank's debt.
In a webcast on emerging markets, IMF managing director Christine Lagarde addressed China's economic direction.
TD Ameritrade CEO Fred Tomczyk, says investors are very active in their portfolio amid volatility, in discussing the impact of Fed policy.
Stocks are doing something rare on Thursday: Nothing.